22nd Century (XXII) Stock Analysis

What 22nd Century does

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

Key metrics

ETFs linked to XXII

Broad-market and Consumer Defensive sector ETFs an investor holding 22nd Century is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how XXII fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for 22nd Century?

22nd Century trades under the ticker XXII on NASDAQ.

Which exchange is XXII listed on?

XXII is listed on NASDAQ.

What sector does 22nd Century operate in?

22nd Century is classified in the Consumer Defensive sector (Tobacco industry).

How can PortView help analyze XXII in a portfolio?

PortView shows XXII's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.